Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Amit Trivedi, HIMSS director of informatics and health IT standards explains the human factor in interoperability is often overlooked. #HIMSS #HIMSS23

Health IT needs to develop its workforce and become more involved in setting informatics standards

Amit Trivedi, HIMSS director of informatics and health IT standards, explains the importance of the human role in interoperability.

artificial intelligence warning united nations

Int’l panel: Safeguard human health against AI now—or risk losing the chance forever

As the world grapples with the potential downsides of generative AI, a global group of healthcare researchers is warning of health perils that could emanate from well beyond clinical settings.

Exploring diversity, compensation among academic cardiothoracic surgeons

New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen in this important specialty. 

insurance payer payment insurer

'Burdensome' Medicare Advantage prior authorization requirements cause delays or denials at 97% of practices

A new Medical Group Management Association report details how the problematic policies are negatively impacting patient care.

CDC director announces her resignation from the agency

News of the CDC director’s departure comes on the same day as an announcement made by the World Health Organization declaring the end of the COVID global health emergency.

Thumbnail

New CMS code could pave the way for coverage of virtual reality-based treatments

The determination places the device under the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) benefit category. 

cardiologist doctor physician patient black diverse hypertension

Q&A: Why the future of physician payments is looking brighter

Health Exec caught up with Claire Ernst from MGMA to learn more about the possibility of physician payments being tied to inflation in the future.

The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

Eli Lilly targets FDA approval for weight loss medication

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

Displaying 369 - 376 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup